Steatohepatitis
Information
- Disease name
- Steatohepatitis
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes | Mutation | Description | Source | Links |
---|
NCT ID | Status | Phase | Summary | Start date | Completion date |
---|---|---|---|---|---|
NCT00326482 | Active, not recruiting | Liver Fibrosis in HIV-Infected Patients With Elevated Liver Enzymes on Antiretroviral Therapy | July 31, 2006 | ||
NCT02378259 | Active, not recruiting | N/A | Randomized Clinical Trial; Medical vs Bariatric Surgery for Adolescents (13-16 y) With Severe Obesity | August 15, 2014 | June 2034 |
NCT04063826 | Active, not recruiting | N/A | PET-MR Study of Fatty Liver | April 10, 2018 | December 31, 2023 |
NCT05946330 | Active, not recruiting | N/A | Nutritional Intervention IN Nash NON-ALCOHOLIC (NAFLD). | February 22, 2023 | July 31, 2024 |
NCT00886301 | Completed | N/A | Fatty Liver and Ectopic Fat in Overweight and Obese Patients | March 2010 | October 2, 2014 |
NCT01147523 | Completed | Phase 2 | Effect of Spironolactone and Vitamin E in Patients With Nonalcoholic Fatty Liver Disease | January 2010 | December 2011 |
NCT01154985 | Completed | Phase 2 | Double-Blind, Placebo-Controlled Study of Two Doses of EPA-E in Patients With Non Alcoholic Steatohepatitis (NASH) | June 2010 | October 2012 |
NCT01645852 | Completed | N/A | A Phase II Study of the Effect of a Low Calorie Diet on Patients Undergoing Liver Resection | June 2012 | December 2016 |
NCT02009592 | Completed | N/A | Efficacy of Rifaximin on Hepatosteatosis and Steatohepatitis Patients | June 2013 | February 2014 |
NCT03915002 | Completed | Integrated Approaches for Identifying Molecular Targets in Liver Disease | June 13, 2019 | April 12, 2023 | |
NCT00512512 | Completed | Transoral Endoscopic Liver Biopsy During Laparoscopic Gastric Bypass | June 2007 | June 2009 | |
NCT00575757 | Completed | Relationship of Metabolic Abnormalities to Hepatic Steatosis in HIV | July 2007 | July 2016 | |
NCT01476995 | Completed | Prognostic Indicators as Provided by the EPIC ClearView | September 2010 | June 2011 | |
NCT01556113 | Completed | N/A | Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease | March 2012 | February 2017 |
NCT05640947 | Recruiting | N/A | Endoscopic Ultrasound-guided Large Diameter Lumen-apposing Metal Stent Gastro-gastrostomy for Bypass Reversal in Patients With Roux-en-y Gastric Bypass | January 30, 2023 | February 2026 |
NCT05864391 | Terminated | Phase 1 | A Study to Investigate Safety, Tolerability, and Pharmacokinetics of AZD7503 in Participants With Suspected NASH. | March 31, 2023 | March 20, 2024 |
NCT01523639 | Terminated | Phase 2 | A Randomized, Placebo-controlled, Double-blind Phase II Study Evaluating if Glucophage Can Avoid Liver Injury Due to Chemotherapy Associated Steatosis | April 2012 | April 2014 |
NCT01246388 | Unknown status | Non-Invasive Evaluation of Fibrosis and Steatosis in Chronic Hepatopathy | May 2010 | December 2014 | |
NCT00914446 | Unknown status | N/A | Identification of Protective and Worsening Steatohepatitis (NASH) Factors | April 2008 | April 2010 |